Gramignoli Roberto, Tahan Veysel, Dorko Kenneth, Skvorak Kristen J, Hansel Marc C, Zhao Wenchen, Venkataramanan Raman, Ellis Ewa C S, Jorns Carl, Ericzon Bo-Goran, Rosenborg Staffan, Kuiper Raoul, Soltys Kyle A, Mazariegos George V, Fox Ira J, Wilson Elizabeth M, Grompe Markus, Strom Stephen C
Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Stockholm, Sweden.
Stem Cell Res. 2013 Jul;11(1):563-73. doi: 10.1016/j.scr.2013.03.002. Epub 2013 Mar 27.
Domino liver transplantation is a method used to increase the number of liver grafts available for orthotopic liver transplantation (OLT). Reports indicate that livers from patients with metabolic liver disease can be safely transplanted into select recipients if the donor's defect and the recipient's metabolic needs are carefully considered. The liver of patients with many types of metabolic liver disease is morphologically and biochemically normal, except for the mutation that characterizes that disease. Other biochemical functions normally performed by the liver are present and presumably "normal" in these hepatocytes. Hepatocytes were isolated from the liver of 35 organ donors and 35 liver tissues taken at OLT from patients with liver disease were analyzed for 9 different measures of viability and function. The data indicate that cells isolated from some diseased livers performed as well or better than those isolated from organ donors with respect to viability, cell yield, plating efficiency and in assays of liver function, including drug metabolism, conjugation reactions and ammonia metabolism. Cells from metabolic diseased livers rapidly and efficiently repopulated a mouse liver upon transplantation.
As with domino liver transplantation, domino cell transplantation deserves consideration as method to extend the pool of available organs and cells for transplantation.
多米诺肝移植是一种用于增加可用于原位肝移植(OLT)的肝移植物数量的方法。报告表明,如果仔细考虑供体的缺陷和受体的代谢需求,患有代谢性肝病患者的肝脏可以安全地移植给特定受体。除了表征该疾病的突变外,许多类型代谢性肝病患者的肝脏在形态和生化方面是正常的。肝脏通常执行的其他生化功能在这些肝细胞中存在且据推测是“正常的”。从35名器官供体的肝脏中分离出肝细胞,并对从肝病患者OLT手术中获取的35份肝组织进行了9种不同的活力和功能检测。数据表明,就活力、细胞产量、接种效率以及包括药物代谢、结合反应和氨代谢在内的肝功能检测而言,从一些患病肝脏分离出的细胞表现与从器官供体分离出的细胞一样好或更好。代谢性患病肝脏的细胞在移植后能迅速有效地重新填充小鼠肝脏。
与多米诺肝移植一样,多米诺细胞移植作为一种扩大可用于移植的器官和细胞库的方法值得考虑。